- Home
- SCYX vs TOPS Comparison
SCYX vs TOPS Comparison
Compare SCYX & TOPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- TOPS
- Stock Information
- Founded
- SCYX 1999
- TOPS 2000
- Country
- SCYX United States
- TOPS Greece
- Employees
- SCYX N/A
- TOPS N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- TOPS Marine Transportation
- Sector
- SCYX Health Care
- TOPS Consumer Discretionary
- Exchange
- SCYX Nasdaq
- TOPS Nasdaq
- Market Cap
- SCYX 28.5M
- TOPS 27.2M
- IPO Year
- SCYX 2014
- TOPS 2004
- Fundamental
- Price
- SCYX $0.70
- TOPS $6.25
- Analyst Decision
- SCYX
- TOPS
- Analyst Count
- SCYX 0
- TOPS 0
- Target Price
- SCYX N/A
- TOPS N/A
- AVG Volume (30 Days)
- SCYX 182.9K
- TOPS 17.5K
- Earning Date
- SCYX 08-07-2025
- TOPS 08-08-2025
- Dividend Yield
- SCYX N/A
- TOPS N/A
- EPS Growth
- SCYX N/A
- TOPS N/A
- EPS
- SCYX N/A
- TOPS 1.09
- Revenue
- SCYX $2,630,000.00
- TOPS $86,127,000.00
- Revenue This Year
- SCYX $410.22
- TOPS $9.90
- Revenue Next Year
- SCYX $248.83
- TOPS N/A
- P/E Ratio
- SCYX N/A
- TOPS $5.79
- Revenue Growth
- SCYX N/A
- TOPS 3.83
- 52 Week Low
- SCYX $0.66
- TOPS $5.00
- 52 Week High
- SCYX $2.21
- TOPS $11.47
- Technical
- Relative Strength Index (RSI)
- SCYX 43.16
- TOPS 48.90
- Support Level
- SCYX $0.67
- TOPS $5.99
- Resistance Level
- SCYX $0.74
- TOPS $6.36
- Average True Range (ATR)
- SCYX 0.04
- TOPS 0.34
- MACD
- SCYX 0.00
- TOPS 0.02
- Stochastic Oscillator
- SCYX 18.79
- TOPS 35.14
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.